Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NEOGENOMICS INC Director's Dealing 2024

Feb 27, 2024

32227_dirs_2024-02-27_cefaa3d1-7b59-4719-b8de-6c4c7824beb0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2024-02-23

Reporting Person: Sherman Jeffrey Scott (Chief Financial Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-02-23 Stock Option (Right to Buy) $16.45 A 77913 Acquired 2034-02-23 Common Stock (77913) Direct
2024-02-23 Restricted Stock Unit $0 A 46606 Acquired Common Stock (46606) Direct
2024-02-23 Performance Stock Unit $0 A 46606 Acquired Common Stock (46606) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 125662 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (Right to Buy) $11.62 2029-12-05 Common Stock (249169) 249169 Direct
Stock Option (Right to Buy) $19.65 2030-05-11 Common Stock (73016) 73016 Direct
Restricted Stock Unit $0 Common Stock (39016) 39016 Direct
Performance Stock Unit $0 Common Stock (39016) 39016 Direct

Footnotes

F1: On December 5, 2022, Mr. Sherman was granted 249,169 stock options. These awards vest ratably over four years with the first tranche vesting on December 7, 2023.

F2: On May 11, 2023, Mr. Sherman was granted 73,016 stock options. These options vest ratably over the first three anniversary dates of the grant date.

F3: On May 11, 2023, Mr. Sherman was granted 39,016 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.

F4: Once vested, the shares of common stock are not subject to expiration.

F5: On May 11, 2023, Mr. Sherman was granted 39,016 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 58,524. The number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company.

F6: On February 23, 2024, Mr. Sherman was granted 77,913 stock options. These options vest ratably over the first three anniversary dates of the grant date.

F7: On February 23, 2024, Mr. Sherman was granted 46,606 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.

F8: On February 23, 2024, Mr. Sherman was granted 46,606 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 69,910. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.